BIOSCRIPT STIRLING LIMITED - Profile & Financials

Accounts Submitted 27 Jun 2025

Confirmation Statement Submitted 6 Feb 2025

Net assets £8.82M £3.02M 2024 year on year

Total assets £0.00 £11.18M 2024 year on year

Total Liabilities £9.10M £3.72M 2024 year on year

Charges 2

2 outstanding

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

Suite A, Greenway House Larkwood Way Tytherington Business Park Macclesfield SK10 2XR England

Office (Macclesfield)

Nether Alderley, Macclesfield SK10 4EL

Office (UK)

The Ropewalks Newton Street Macclesfield Cheshire SK11 6QJ

Office (USA)

103 Carnegie Center Suite 300 Princeton, NJ 08540 6235

Telephone

004930887060103

careers@bioscriptgroup.com

Website

bioscriptgroup.com

Credit Report

Discover BIOSCRIPT STIRLING LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2024

Type Total Exemption Full

Next accounts 31 December 2025

Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2013–2024)

Cash in Bank

£808.50k

Increased by £376.28k (+87%)

Net Assets

£8.82M

Increased by £3.02M (+52%)

Total Liabilities

£9.10M

Increased by £3.72M (+69%)

Turnover

£11.93M

Increased by £914.24k (+8%)

Employees

Decreased by 2 (-2%)

Debt Ratio

N/A

Decreased by 48 (-100%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 Dec Year End	2023 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

2 active 10 resigned

Show resigned officers

						Status
Gabrielle Alison Silver	Director	British	England	52	15 Feb 2024	Active
James Maxwell	Director	British	United Kingdom	41	15 Feb 2024	Active

Shareholders

Shareholders (1)


Bioscript Group Limited	100.0%	39,474	Ordinary	6 Feb 2025

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Bioscript Group Limited

United Kingdom

Active

Notified 17 Jan 2017

Nature of Control

Voting Rights 75 To 100 Percent

See All Controllers

Group Structure

BIOSCRIPT GROUP LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

BIOSCRIPT LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

BIOSCRIPT MIDCO 2 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

BIOSCRIPT MIDCO 1 LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

BIOSCRIPT HOLDINGS LIMITED united kingdom significant influence or control

SOVEREIGN CAPITAL PARTNERS LLP united kingdom

BB SHELF 4 LLP united kingdom voting rights 75 to 100 percent limited liability partnership

BIOSCRIPT STIRLING LIMITED Current Company

Charges

2 outstanding

Documents

Company Filings

Date	Category	Description	Document
27 Jun 2025	Accounts	Annual accounts made up to 2024-09-30	View(32 pages)
7 Feb 2025	Officers	Change to director Mr James Maxwell on 2025-02-06	View(2 pages)
6 Feb 2025	Confirmation Statement	Confirmation statement made on 2025-01-23 with updates	View(5 pages)
1 Oct 2024	Officers	Change to director Mr James Maxwell on 2024-09-24	View(2 pages)
1 Oct 2024	Persons With Significant Control	Change to Bioscript Group Limited as a person with significant control on 2024-09-24	View(2 pages)